TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biobank AS
Closing information (x1000 EUR)
| Closing information | 2019/12 | 2018/12 | 2017/12 |
| Turnover |
1,887
|
1,621
|
1,665 |
| Financial expenses |
6
|
7
|
9 |
| Earnings before taxes |
218
|
176
|
230 |
| Total assets |
1,331
|
1,082
|
940 |
| Current assets |
1,028
|
705
|
577 |
| Current liabilities |
250
|
204
|
186 |
| Equity capital |
745
|
563
|
562 |
| - share capital |
30
|
30
|
30 |
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Solvency |
56.0%
|
52.0%
|
59.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
11.6%
|
10.9%
|
13.8% |
| Return on assets (ROA) |
16.8%
|
16.9%
|
25.4% |
| Current ratio |
411.2%
|
345.6%
|
310.2% |
| Return on equity (ROE) |
29.3%
|
31.3%
|
40.9% |
| Change turnover |
238
|
-13
|
618 |
| Change turnover % |
14%
|
-1%
|
59% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.